Patents-Review.com
ClassID:

110960 ⎘

C12N2760/18432 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Paramyxoviridae; Morbillivirus, e.g. Measles virus, canine distemper Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Recent Application in this class:
#1
20240165178
2024-05-23

MATERIALS AND METHODS FOR TREATING CANCER

 #2
20230279429
2023-09-07

DNA MOLECULES PRODUCING CUSTOM DESIGNED REPLICATING AND NON-REPLICATING NEGATIVE STRANDED RNA VIRUSES AND USES THERE OF

 #3
20230272423
2023-08-31

DNA MOLECULES PRODUCING CUSTOM DESIGNED REPLICATING AND NON-REPLICATING NEGATIVE STRANDED RNA VIRUSES AND USES THERE OF

 #4
20230016479
2023-01-19

METHOD FOR PREPARING MESENCHYMAL STEM CELLS HAVING IMPROVED VIABILITY THROUGH ANTI-CANCER VIRUS INTRODUCTION

 #5
20210252085
2021-08-19

RNA viruses for immunovirotherapy

 #6
20200239866
2020-07-30

DEGRON FUSION CONSTRUCTS AND METHODS FOR CONTROLLING PROTEIN PRODUCTION

 #7
20200016260
2020-01-16

Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy

 #8
20190365836
2019-12-05

Materials and methods for treating cancer

 #9
20190211355
2019-07-11

DNA molecules producing custom designed replicating and non-replicating negative stranded RNA viruses and uses there of

 #10
20190099461
2019-04-04

RNA VIRUSES FOR IMMUNOVIROTHERAPY

 #11
20180280425
2018-10-04

Adjuvant composition

 #12
20180221469
2018-08-09

Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy

 #13
20180105802
2018-04-19

Viral Targeting with Knottins

 #14
20170247425
2017-08-31

RNA viruses expressing IL-12 for immunovirotherapy

 #15
20170128505
2017-05-11

RNA viruses for immunovirotherapy

 #16
20170065650
2017-03-09

RNA viruses for immunovirotherapy

 #17
20150359873
2015-12-17

Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy

 #18
20150250838
2015-09-10

Oncolytic measles virus

 #19
20150209423
2015-07-30

Medicaments and methods for treating mesothelioma

 #20
20130295114
2013-11-07

PVRL4 (Nectin4) is a receptor for measles virus

 #21
20130217757
2013-08-22

Oncolytic measles virus

 #22
20110142811
2011-06-16

MEASLES VIRUS FOR THE ELIMINATION OF UNWANTED CELL POPULATIONS

 #23
20110014231
2011-01-20

ANTI-MEASLES CANCER IMMUNOTHERAPY

 #24
20100278872
2010-11-04

Medicaments and methods for treating mesothelioma

 #25
20100119548
2010-05-13

Method for limiting the growth of cancer cells using an attenuated measles virus

 #26
20090004149
2009-01-01

Method for limiting the growth of cancer cells using an attenuated measles virus

 #27
20070071771
2007-03-29

Method for limiting the growth of cancer cells using an attenuated measles virus

 #28
20050271621
2005-12-08

Ablated SLAM-Dependent Entry